A Phase I, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB050465 Monotherapy and in Combination with INCB039110 in Subjects with Previously Treated B-Cell Malignancies - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB050465 Monotherapy and in Combination with INCB039110 in Subjects with Previously Treated B-Cell Malignancies

Type of Cancer
Lung
Locations
Hackensack
Sponsor
Incyte INCB
Protocol Number
50465-101
Cancer Diagnosis
To Learn More Call
201-510-0910